Acquisition by Epperly Corinne of 54800 shares of In8bioInc at 1.04 subject to Rule 16b-3
INAB Stock | USD 0.37 0.07 23.33% |
About 69 percent of all In8bio's investors are curious in acquiring. The analysis of the overall investor sentiment regarding In8bio Inc suggests that quite a large number of traders are confidant. The current market sentiment, together with In8bio's historical and current headlines, can help investors time the market. In addition, many technical investors use In8bio Inc stock news signals to limit their universe of possible portfolio assets.
In8bio |
Filed transaction by In8bioInc Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
In8bio's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the In8bio's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
In8bio Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards In8bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
In8bio Fundamental Analysis
We analyze In8bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of In8bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of In8bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
In8bio is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
In8bio Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with In8bio stock to make a market-neutral strategy. Peer analysis of In8bio could also be used in its relative valuation, which is a method of valuing In8bio by comparing valuation metrics with similar companies.
Peers
In8bio Related Equities
INMB | INmune Bio | 6.93 | ||||
WINT | Windtree Therapeutics | 1.89 | ||||
CNSP | Cns Pharmaceuticals | 1.82 | ||||
WVE | Wave Life | 1.13 | ||||
PYPD | PolyPid | 1.50 | ||||
LTRN | Lantern Pharma | 1.56 | ||||
ALLR | Allarity Therapeutics | 1.82 | ||||
ANNX | Annexon | 2.23 | ||||
PALI | Palisade Bio | 2.44 | ||||
RVPH | Reviva Pharmaceuticals | 3.23 | ||||
CUE | Cue Biopharma | 4.10 | ||||
ANIX | Anixa Biosciences | 4.85 | ||||
TFFP | Tff Pharmaceuticals | 5.29 | ||||
GANX | Gain Therapeutics | 5.91 | ||||
ZURA | Zura Bio | 8.20 |
Complementary Tools for In8bio Stock analysis
When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |